Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel

被引:11
|
作者
Shah, Vishal P. [1 ,2 ]
Breeher, Laura E. [1 ,3 ]
Alleckson, Julie M. [3 ]
Rivers, David G. [3 ]
Wang, Zhen [2 ]
Stratton, Emily R. [1 ]
Farah, Wigdan [1 ]
Hainy, Caitlin M. [3 ]
Swift, Melanie D. [1 ,3 ]
机构
[1] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA
[2] Mayo Clin, Evidence Based Practice Res Program, Rochester, MN 55905 USA
[3] Mayo Clin, Occupat Hlth Serv, Rochester, MN USA
关键词
COVID-19; WORKERS;
D O I
10.1017/ice.2021.533
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To assess the rate and factors associated with healthcare personnel (HCP) testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) after an occupational exposure. Design: Retrospective cohort study. Setting: Academic medical center with sites in Minnesota, Wisconsin, Arizona, and Florida. Participants: HCP with a high or medium risk occupational exposure to a patient or other HCP with SARS-CoV-2. Methods: We reviewed the records of HCP with significant occupational exposures from March 20, 2020, through December 31, 2020. We then performed regression analysis to assess the impact of demographic and occupational variables to assess their impact on the likelihood of testing positive for SARS-CoV-2. Results: In total, 2,253 confirmed occupational exposures occurred during the study period. Employees were the source for 57.1% of exposures. Overall, 101 HCP (4.5%) tested positive in the postexposure period. Of these, 80 had employee sources of exposure and 21 had patient sources of exposure. The postexposure infection rate was 6.2% when employees were the source, compared to 2.2% with patient sources. In a multivariate analysis, occupational exposure from an employee source had a higher risk of testing positive compared to a patient source (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.72-6.04). Sex, age, high-risk exposure, and HCP role were not associated with an increased risk of testing positive. Conclusions: The risk of acquiring coronavirus disease 2019 (COVID-19) following a significant occupational exposure has remained relatively low, even in the prevaccination era. Exposure to an infectious coworker carries a higher risk than exposure to a patient. Continued vigilance and precautions remain necessary in healthcare settings.
引用
收藏
页码:1785 / 1789
页数:5
相关论文
共 50 条
  • [31] Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    Zhang, Yue-miao
    Zhang, Hong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (07): : 1044 - 1046
  • [32] Invasive Listeriosis After Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection
    Wang, Yu Ching
    Hsu, Hsiang-Chin
    Shih, Hsin-, I
    JOURNAL OF ACUTE MEDICINE, 2024, 14 (03) : 130 - 133
  • [33] Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population
    Rennert, Lior
    McMahan, Christopher
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (04) : 719 - 722
  • [34] Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia
    Ahmed, Waleed A.
    Dada, Ashraf
    Alshukairi, Abeer N.
    Sohrab, Sayed S.
    Faizo, Arwa A.
    Tolah, Ahmed M.
    El-Kafrawy, Sherif A.
    Bajrai, Leena H.
    Moalim, Hanan M.
    Aly, Mohamed H.
    Aboelazm, Ahmed F.
    Al-Hamzi, Mohammed A.
    Saeedi, Mohammed F.
    Alandijany, Thamir A.
    Azhar, Esam, I
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (03)
  • [35] Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry
    Wandernoth, Petra
    Kriegsmann, Katharina
    Groh-Mohanu, Cristina
    Daeumer, Martin
    Gohl, Peter
    Harzer, Oliver
    Kriegsmann, Mark
    Kriegsmann, Joerg
    VIRUSES-BASEL, 2020, 12 (08):
  • [36] The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations
    Lippi, Giuseppe
    Henry, Brandon M.
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [37] Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
    Tulimilli, SubbaRao, V
    Dallavalasa, Siva
    Basavaraju, Chaithanya G.
    Rao, Vinay Kumar
    Chikkahonnaiah, Prashanth
    Madhunapantula, SubbaRao, V
    Veeranna, Ravindra P.
    VACCINES, 2022, 10 (10)
  • [38] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?
    Nisole, Sebastien
    Saulnier, Aure
    Gatignol, Anne
    VIROLOGIE, 2020, 24 (03) : 135 - 141
  • [39] Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Pecetta, Simone
    Kratochvil, Sven
    Kato, Yu
    Vadivelu, Kumaran
    Rappuoli, Rino
    PHARMACOLOGICAL REVIEWS, 2022, 74 (01) : 313 - 339
  • [40] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update
    Brix, Thomas H.
    Hegedus, Laszlo
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2021, 28 (05) : 525 - 532